Literature DB >> 20722792

Simple strategies for vaginal health promotion in cancer survivors.

Jeanne Carter1, Deborah Goldfrank, Leslie R Schover.   

Abstract

INTRODUCTION: With the population of cancer survivors nearing 12 million, an ever-increasing number of women will face vaginal health issues related to their disease and/or treatment. Abrupt menopause triggered by cancer treatment, for example, can cause intense and prolonged estrogen deprivation symptoms, including vaginal dryness and discomfort. Simple strategies to promote vaginal health are available. AIMS: To provide a comprehensive overview of vaginal health issues caused by estrogen deprivation in female cancer patients/survivors and provide recommendations to identify, treat, and promote vaginal health.
METHODS: We describe a treatment algorithm, based on scientific literature and supported by clinical experience, found to be effective in treating these patients at two major cancer centers. We also provide examples of handouts for patient education on vaginal health promotion. MAIN OUTCOME MEASURES: Evidence-based medicine and psychosocial literature, in addition to clinical experience at two major cancer centers.
RESULTS: Simple, non-hormonal interventions for sexual dysfunction are often overlooked. Several studies show that education on vaginal lubricants, moisturizers, and dilator use (as needed) can decrease the morbidity of vaginal atrophy. These studies also provide support for our clinical treatment recommendations. Our goal in this article is to increase awareness of these strategies and to provide assistance to general gynecologists and oncologists caring for cancer patients and survivors.
CONCLUSIONS: Dedicating a small amount of time to educate female cancer survivors about methods to promote vaginal health can result in the reduction or elimination of vaginal discomfort. Non-hormonal vaginal health strategies often appear sufficient to remedy these issues. However, large randomized trials are needed, varying the format and components of the treatment program and exploring efficacy in various groups of female cancer survivors.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722792     DOI: 10.1111/j.1743-6109.2010.01988.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  38 in total

1.  Premature menopause in young breast cancer: effects on quality of life and treatment interventions.

Authors:  Shoshana M Rosenberg; Ann H Partridge
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.

Authors:  Shoshana M Rosenberg; Annette L Stanton; Keith J Petrie; Ann H Partridge
Journal:  Oncologist       Date:  2015-05-01

3.  A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.

Authors:  Pragati Advani; Abenaa M Brewster; George P Baum; Leslie R Schover
Journal:  J Cancer Surviv       Date:  2017-02-22       Impact factor: 4.442

4.  Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.

Authors:  Jeanne Carter; Cara Stabile; Barbara Seidel; Raymond E Baser; Abigail R Gunn; Stephanie Chi; Rebecca F Steed; Shari Goldfarb; Deborah J Goldfrank
Journal:  Support Care Cancer       Date:  2015-01-08       Impact factor: 3.603

5.  Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer.

Authors:  Kimberley Cullen; Karen Fergus; Tracey DasGupta; Iwa Kong; Marg Fitch; Catherine Doyle; Lauran Adams
Journal:  Support Care Cancer       Date:  2013-02-17       Impact factor: 3.603

6.  Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.

Authors:  Leslie R Schover; George P Baum; Lisa A Fuson; Abenaa Brewster; Amal Melhem-Bertrandt
Journal:  J Sex Med       Date:  2014-08-21       Impact factor: 3.802

Review 7.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

Review 8.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

9.  Talking about women's sexual health after cancer: Why is it so hard to move the needle?

Authors:  Jennifer Barsky Reese; Sharon L Bober; Mary B Daly
Journal:  Cancer       Date:  2017-11-08       Impact factor: 6.860

10.  Adapting a couple-based intimacy enhancement intervention to breast cancer: A developmental study.

Authors:  Jennifer Barsky Reese; Laura S Porter; Kristen E Casale; Elissa T Bantug; Sharon L Bober; Sharon C Schwartz; Katherine Clegg Smith
Journal:  Health Psychol       Date:  2016-08-15       Impact factor: 4.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.